These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31227876)

  • 41. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins.
    Ascher E; Jacob T; Hingorani A; Tsemekhin B; Gunduz Y
    J Vasc Surg; 2001 May; 33(5):1080-6. PubMed ID: 11331852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study.
    Badier-Commander C; Couvelard A; Henin D; Verbeuren T; Michel JB; Jacob MP
    J Pathol; 2001 Mar; 193(3):398-407. PubMed ID: 11241422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma endothelin-1 release in normal and varicose saphenous veins.
    Mangiafico RA; Malatino LS; Santonocito M; Spada RS; Benedetto FA
    Angiology; 1997 Sep; 48(9):769-74. PubMed ID: 9313626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ca2+ mobilization in saphenous vein smooth muscle cells derived from patients with primary varicosity.
    Schuller-Petrovic S; Stessel H; Brunner F
    Eur J Clin Invest; 2002 Sep; 32(9):649-56. PubMed ID: 12486863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smooth muscle cell apoptosis in primary varicose veins.
    Urbanek T; Skop B; Wiaderkiewicz R; Wilczok T; Ziaja K; Lebda-Wyborny T; Pawlicki K
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):600-11. PubMed ID: 15531194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shear Stress Alterations Activate BMP4/pSMAD5 Signaling and Induce Endothelial Mesenchymal Transition in Varicose Veins.
    Chandran Latha K; Sreekumar A; Beena V; S S BR; Lakkappa RB; Kalyani R; Nair R; Kalpana SR; Kartha CC; Surendran S
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative greater saphenous vein-sparing surgery: valvuloplasty combined with axial transposition of a competent tributary vein for the treatment of primary valvular incompetence---18-month follow-up.
    Yamaki T; Nozaki M; Sasaki K
    Dermatol Surg; 2002 Feb; 28(2):162-7. PubMed ID: 11860429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen Receptors and Chronic Venous Disease.
    Serra R; Gallelli L; Perri P; De Francesco EM; Rigiracciolo DC; Mastroroberto P; Maggiolini M; de Franciscis S
    Eur J Vasc Endovasc Surg; 2016 Jul; 52(1):114-8. PubMed ID: 27220899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins.
    Gandhi RH; Irizarry E; Nackman GB; Halpern VJ; Mulcare RJ; Tilson MD
    J Vasc Surg; 1993 Nov; 18(5):814-20. PubMed ID: 8230568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of endothelin receptors in human varicose veins.
    Barber DA; Wang X; Gloviczki P; Miller VM
    J Vasc Surg; 1997 Jul; 26(1):61-9. PubMed ID: 9240323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Venous hemodynamic changes in the surgical treatment of primary varicose vein of the lower limbs.
    Kim IH; Joh JH; Kim DI
    Yonsei Med J; 2004 Aug; 45(4):577-83. PubMed ID: 15344196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic cells in venous pathologies.
    Cherian SM; Bobryshev YV; Inder SJ; Lord RS; Ashwell KW
    Angiology; 1999 May; 50(5):393-402. PubMed ID: 10348427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers of low-grade inflammation in primary varicose veins of the lower limbs.
    Flore R; Ponziani FR; Gerardino L; Santoliquido A; Di Giorgio A; Lupascu A; Nesci A; Tondi P
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):557-62. PubMed ID: 25753870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of reactive oxygen metabolites by the varicose vein wall.
    Glowinski J; Glowinski S
    Eur J Vasc Endovasc Surg; 2002 Jun; 23(6):550-5. PubMed ID: 12093073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. More great saphenous vein valves - less varicose veins?
    Gräub AB; Naef M; Wagner HE; Mouton WG
    Vasa; 2014 Jul; 43(4):260-5. PubMed ID: 25007904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Why and when to preserve the saphenous veins of varicose patients to serve as an arterial bypass?].
    Mellière D
    J Mal Vasc; 1994; 19(3):216-21. PubMed ID: 7798809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The scanning electron microscope in the pathology of varicose veins.
    Mashiah A; Rose SS; Hod I
    Isr J Med Sci; 1991 Apr; 27(4):202-6. PubMed ID: 2010274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Varicose disease affects the P2 receptor-mediated responses of human greater saphenous vein.
    Ziganshin AU; Khaziakhmetov DF; Ziganshina LE; Khaziakhmetova VN; Jourjikiya RK; Ziganshin BA; Giniyatova LR; Burnstock G
    Vascul Pharmacol; 2004 Aug; 42(1):17-21. PubMed ID: 15664883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins.
    Jacob T; Hingorani A; Ascher E
    J Vasc Surg; 2005 Mar; 41(3):523-30. PubMed ID: 15838489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endovenous laser ablation (EVLA) of the anterior accessory great saphenous vein (AAGSV): abolition of sapheno-femoral reflux with preservation of the great saphenous vein.
    Theivacumar NS; Darwood RJ; Gough MJ
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):477-81. PubMed ID: 19201621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.